FIVE PRIME THERAPEUTICS, INC.·4

Sep 4, 1:18 PM ET

Knickerbocker Aron Marc 4

4 · FIVE PRIME THERAPEUTICS, INC. · Filed Sep 4, 2019

Insider Transaction Report

Form 4
Period: 2019-09-01
Knickerbocker Aron Marc
SVP & Chief Business Officer
Transactions
  • Tax Payment

    Common Stock

    2019-09-01$5.43/sh3,306$17,95242,057 total
Holdings
  • Common Stock

    (indirect: By Trust)
    200,299
Footnotes (2)
  • [F1]Since the date of the reporting person's last ownership report, he transferred 2,848 shares of common stock to the Aron M. Knickerbocker Revocable Trust.
  • [F2]Includes 1,623 shares acquired on May 15, 2019 pursuant to Five Prime Therapeutics, Inc.'s 2013 Employee Stock Purchase Plan.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION